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Objectives: To perform detailed analysis of stent expansion, vessel wall stress, hemodynamics, re-
endothelialization, restenosis, and repeat PCI in the simultaneous kissing stents (SKS) technique of
bifurcation left main stem (LMS) stenting.
Background: The SKS technique is useful to treat patients with true bifurcation disease of the
LMS but remains controversial.
Methods and Results: Computational structural analysis of SKS expansion demonstrated undis-
torted and evenly expanded stents. Computational fluid dynamics modelling revealed largely
undisturbed blood flow. 239 PCI procedures were performed on 217 patients with unprotected
bifurcation LMS disease with SKS using DES (2004-2017). We electively studied 13 stable patients
from baseline to 10 years post-SKS with repeat angiography and optical coherence tomography,
and demonstrated tissue coverage of the stent struts at the carina, with no evidence of lacunae
behind the stents. We studied all patients with symptomatic recurrence. Target lesion revasculari-
zation rate was 3.2% at 1 year and 4.6% at 2 years. Of all 20 patients with restenosis, the site was
the LMS-Cx stent in 7, the LMS-LAD stent in 2 and both in 11. Two-year recurrence rate was 7/
32 (5.3%) for first, and 4/108 (3.7%) for second generation DES. Treatment with repeat kissing
techniques was undertaken in 19/20, with sustained clinical results with re-SKS.
Conclusion: The SKS technique for treating unprotected LMS bifurcation disease does not distort
the stents, is associated with favorable hemodynamics, tissue coverage of the exposed struts, and
a low restenosis rate when performed with contemporary stents. Re-PCI with repeat SKS appears
feasible, safe, and durable.
K E YWORD S
bifurcation, computational fluid dynamics, left main coronary artery, optical coherence tomogra-
phy, percutaneous coronary intervention, restenosis
Abbreviations: ACS, acute coronary syndromes; ACT, activated clotting time; Atm, atmospheres (pressure); Cx, circumflex coronary artery; DES, drug-eluting
stents; EXCEL, Evaluation of XIENCE Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial; IABP, intra-aortic
balloon pump; IQR, interquartile range; LAD, left anterior descending coronary artery; LMS, left main stem; MACCE, major adverse cardiac and cerebrovascular
events; NOBLE, percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE); NSTE-ACS,
non-ST elevation acute coronary syndrome; POBA, plain old balloon angioplasty; PCI, percutaneous coronary intervention; SKS, simultaneous kissing stents;
SYNTAX, the synergy between percutaneous coronary intervention with Taxus and cardiac surgery (trial); TVR, target vessel revascularization; ULMS, unprotected
left main stem.
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1 | INTRODUCTION
With modern drug-eluting stents, intravascular imaging, physiological
guidance, improved patient selection, and insight from large contempo-
rary trials such as EXCEL and NOBLE, percutaneous coronary interven-
tion (PCI) is assuming an increasing role in the treatment of left main
stem (LMS) disease [1,2].
Approximately 70% of lesions affecting the LMS involve the bifur-
cation. Percutaneous coronary intervention (PCI) of such lesions is both
more challenging and associated with higher risk than for those of the
body or ostium of the LMS [3]. A single stent ‘provisional’ technique is
the most widely used, especially if the circumflex (Cx) is large and mini-
mally diseased, or small and nonsignificant. The results of this approach
are excellent, provided crossover to a two-stent technique is avoided
[4]. Unlike other bifurcations, however, the implications of losing flow
to the Cx, especially when it is large and diseased, are substantial, and
‘bailout’ two-stent techniques are often less than satisfactory. A two-
stent strategy with simultaneous kissing stents (SKS) for true bifurca-
tion disease of the LMS has gained some favor, particularly in the
emergency setting. The first cases of SKS were reported by Colombo
[5], Teirstein [6], and Sharma [7]. We conducted preclinical and early
clinical assessment in a series of 30 patients in the first-generation DES
era, and confirmed its simplicity, high acute success rate, procedural
speed and safety, with systematic angiographic follow-up [8]. We also
provided the overall outcomes of our first 150 unselected cases [9].
The SKS procedure has previously been described in detail [7], but it
remains controversial chiefly because of perceived problems related to the
artificially created carina and the feasibility and approach to re-intervention.
We therefore now present a technical analysis of SKS to address
those concerns, and focus on the mechanics of stent expansion, the
hemodynamics, the extent of re-endothelialization of the carina, the rate
and pattern of restenosis, and the feasibility and safety of repeat PCI.
2 | MATERIALS AND METHODS
2.1 | Computational structural model of SKS
We replicated the SKS procedure ‘virtually’ by performing a finite ele-
ment analysis of stent implantation, as previously done to investigate
FIGURE 1 Mechanical simulation of SKS deployment. A, Virtual SKS deployment sequence of two Resolute IntegrityTM stents at 9 atm
(nominal pressure) in an idealized coronary bifurcation without disease: insertion (top), expansion (center), and recoil after balloon deflation
(bottom). B, Quantification of stent strut malapposition. C, Arterial wall stress (computed as maximum principal stress) induced by SKS. D,
Stent stress (computed as von Mises stress) after SKS [Color figure can be viewed at wileyonlinelibrary.com]
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other coronary bifurcation stenting techniques [10–12]. Two Resolute
IntegrityTM stents (Medtronic, USA) were deployed in SKS pattern in
an idealized geometry comprising a 608 bifurcation measuring 4.0 mm
at the LMS, 3.0 mm at the LAD and 2.5 mm at the Cx, a configuration
obeying Finet’s law (Figure 1). The stent sizes were 3 3 15 mm for the
LAD and 2.5 3 14 mm for the Cx. The balloon model of each stent
was calibrated to comply with the pressure-diameter curve given by
the manufacturer. The structural analysis focused on the geometry of
the deployed stents, deformation, and areas of malapposition. Further-
more, the vessel wall stress induced by the SKS and the stent stress
after SKS were evaluated.
2.2 | Computational fluid dynamics (CFD)
model of SKS
We constructed a CFD model based upon the structural simulations to
analyze the velocity field, regions of disturbed flow and wall shear
stress immediately after SKS procedure. A pulsatile CFD simulation
was performed following a previously described procedure [11,13]. A
typical human LMS flow waveform was applied at the inlet [14]. A
flow-split of 0.6:0.4, calculated using a diameter-based scaling law [15],
was imposed between the LAD and Cx. The lumen and the stents were
considered rigid with a no-slip wall-boundary condition. Blood was
modeled as a non-Newtonian fluid.
2.3 | Patients and setting
The Northern General Hospital, Sheffield Teaching Hospitals NHS
Foundation Trust, Sheffield, UK, is a tertiary Cardiothoracic Centre
serving a population of 1.8 m people living in the North of England. It
is the only PCI center in the region. Approximately 2000 PCIs are per-
formed at NGH annually, and >70% of these cases are nonelective.
We studied all patients with unprotected (ungrafted) LMS (ULMS) dis-
ease in the DES era (2004–2017). In this period, the senior operators
performed 601 PCIs for ULMS disease. The only reason for avoiding
SKS as a LMS bifurcation stenting technique was an exceptionally long,
LMS. First generation DES were available from 2004 to 2009, and sec-
ond generation DES thereafter. The SKS cohort comprised ‘all-comers’,
including many in an acute setting of myocardial infarction, cardiogenic
shock, and those unfit for coronary artery bypass graft (CABG) surgery.
Any patient with recurrent symptoms was referred back to the senior
operator.
FIGURE 2 Simulation of blood flow patterns in SKS using computational fluid dynamics. A, Velocity contours in the middle plane at peak
flow-rate. Panels A1 and A2 show a magnified image of the velocity field with in-plane velocity vectors at the Cx origin and at the carina,
respectively. B, Contour map of time-averaged wall shear stress (WSS). The histogram on the right shows the area distribution of time-
averaged WSS in the stented region. The bars represent the percentage of lumen area with a defined range of time-averaged WSS values.
Bin widths are 0.2 Pa [Color figure can be viewed at wileyonlinelibrary.com]
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2.4 | Optical coherence tomography of SKS
Asymptomatic patients who had previously undergone SKS over a
range of time intervals were screened for inclusion in this study.
Recruits had to be willing to return for re-catheterization, with no con-
traindications; namely frailty, peripheral vascular disease, renal impair-
ment, anticoagulation, a bleeding tendency or inability to tolerate lying
down. Local Ethics Committee approval was obtained (STH16312; UK
REC 12/YH/0010). The patients underwent repeat coronary angiogra-
phy with an 8F guide catheter via the femoral artery or a 7.5F sheath-
less catheter via the radial artery. Angiographic images were recorded.
With dual antiplatelet drug cover, and after a standard dose of heparin,
a guidewire was passed down each branch of the SKS and an optical
coherence tomography (OCT) catheter (OptisTM, St. Jude Medical, St.
Paul, MN) advanced through the SKS wherever possible. Standard pull-
back imaging was then recorded through the LMS stents. The images
were recorded and analyzed offline with particular attention to tissue
coverage of the exposed metal carina.
2.5 | Restenosis rate and angiographic pattern
All patients with recurrent symptoms underwent repeat coronary angi-
ography with a view to repeat PCI during the same procedure. We
recorded the age, sex, clinical indication, presence of diabetes, logistic
New York PCI Risk Score, logistic EuroSCORE, angiographic SYNTAX
score and the original Medina classification of the LMS bifurcation. The
re-catheterization technique was as described above. The pattern of
restenosis was recorded as being in the LMS-LAD stent and/or the
LMS-Cx stent. Patients were offered repeat revascularization whenever
feasible.
2.6 | Percutaneous treatment of SKS restenosis
A guidewire was passed down each ‘limb’ of the SKS, predilatation was
performed, and definitive treatment given with simultaneous expansion
of balloons (drug eluting when available) or stents, aiming to increase
the size of the SKS by 0.5 mm in each stent. The details of revasculari-
zation and the acute success rate were recorded. The long-term results
of patients treated with re-PCI were also documented.
2.7 | Statistical analysis
Descriptive data are presented as mean [standard deviation (SD)],
median [interquartile range (IQR)], or as n (%), as appropriate. Between-
group differences were analyzed using Student’s t tests for continuous
data and Chi-square tests for categorical data. Statistical significance
was accepted at the 95% level.
3 | RESULTS
3.1 | Computational structural model of SKS
The results of the structural analysis of SKS are shown in Figure 1. The
‘virtual’ stents deployed normally and there were no large gaps or
asymmetries between struts. In this undiseased model, there was 33%
stent strut malapposition, with lacunae at the ‘virtual’ vessel carina and
alongside the metallic carina between the two stents in the body of the
LMS (Figure 1). The stresses in the vessel wall at the end of the proce-
dure were moderate (Figure 1). The higher values were located at the
LMS because of the vessel overexpansion caused by the simultaneous
expansion of the two stents. The peak stress was localized at the Cx
ostium opposite to the carina. The stresses in the stents themselves
were also moderate, and located in the welds in the curved region of
the LMS-Cx stent (Figure 1D). The maximum values were 795 MPa at
maximum balloon expansion and 804 MPa after recoil.
3.2 | CFD model of SKS
The velocity field is shown in Figure 2. The presence of the ‘virtual’
metallic carina caused flow separation in the proximal LMS with the
creation of two inner channels and an increase of the flow velocity.
These two channels behaved as an extension of the two daughter
TABLE 1 Characteristics of the 239 ULMS SKS procedures
Characteristic N
Mean age 68.0 (10)
Male gender 168 (70%)
Urgency
Routine 116 (48.5%)
Urgent 87 (36.4%)
Emergency 37 (15.5%)
Comorbiditya
Hypertension 42 (17.5%)
Diabetes mellitus 40 (16.7%)
Renal failure$ 13 (5.4%)
Chronic lung disease 20 (8.4%)
Anemia 19 (7.9%)
Valvular heart disease 30 (12.5%)
Left ventricular systolic impairmentb 51 (21.3%)
Peripheral vascular disease 23 (9.6)
Stroke 10 (4.2%)
Obese 32 (13.3%)
Procedural details
Catastrophic state 16 (6.7)
Intra-aortic balloon
counterpulsation use
40 (16.7%)
Glycoprotein IIbIIIa use 83 (34.7)
Inappropriate or turned
down for surgery
137 (57.3%)
Complete revascularization achieved 171 (71.5%)
Stent details
1st generation DES 55% (all Taxus)
2nd generation DES 45% of which
78% Promus
11% Xience
6% Resolute
4% Endeavour
3% Ultimaster
Mean stent size LMS-LAD 3.10 (0.4) 3 23.1 (5.3) mm
Mean stent size LMS-LCx 3.16 (1.1) 3 22.0 (5.5) mm
aKnown diagnosis at time of procedure. $Creatinine >200 mmol/L.
bbGraded as at least moderate. Data are presented as either mean (SD)
or N (%).
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branches. A small recirculation region was present at the LCX ostium
near the proximal wall. There was blood stagnation outside the metallic
carina in this undiseased model. The contour map of the time-averaged
wall shear stress (TAWSS) along the lumen with the corresponding
area distribution is shown in Figure 2. Low TAWSS were located close
to the stent struts and at the metallic carina. The percentage lumen
area exposed to TAWSS lower than 0.4 Pa was 20.3% in the stented
region. The median TAWSS was 0.58 Pa.
3.3 | Patients
During the period of the registry, 601 ULMS PCI procedures were per-
formed. Thirty of these were in the BMS era and were excluded, 571
LMS procedures were performed using DES. Of these, 239 (42%) were
with SKS. The remaining 332 cases comprised 289 single/provisional
stents, 24 T-stents, 14 POBA, one culotte, two mini-crush and two
unsuccessful procedures. Details of the 217 patients undergoing SKS
for ULMS disease are shown in Table 1, and this includes 20 patients
re-treated for SKS restenosis. Median follow up was 8.3 years. The
mortality rate was 3.3% at 1 year and 5.2% at 2, 64% of these having
originally been urgent or emergency cases.
3.4 | OCT analysis
An OCT catheter was successfully deployed in all 13 patients at the fol-
lowing time-points in months after their index SKS procedure; 3, 4
(two cases), 5 (two cases), 6, 11, 12 (2 cases) 15, 17, 48, and 120. The
catheter was successfully passed down 12/13 LADs and 12/13 Cxs.
Blood clearance and good quality images were obtained in all cases. An
ovoid cross-section of the stents and a flattened inter-stent carina
were consistently seen. The case recorded at three months demon-
strated some uncovered struts within the neocarina. Tissue covered
individual struts seen at the carina in the remaining 12/13 cases, all of
which were taken at four months and beyond. In 7/13 patients there
was a complete layer of tissue with no fenestrations (Figures 3 and 4
and Supporting Information Video 1). The pattern of tissue develop-
ment was similar in all cases; (1) tissue covered individual stent struts in
all cases by four months forming a fenestrated ‘diaphragm’ between
the two barrels of the SKS, (2) endothelial tissue development formed
a continuous (unfenestrated) diaphragm from 4 months onwards, and
(3) the complete diaphragm propagated in the direction from the neo-
carina towards the LMS ostium. OCT results for each case are summar-
ized in Table 2.
3.5 | Symptomatic recurrence
Of the 217 patients who underwent SKS, the running total of clinical
recurrence was 7 by 1 year (3.2%), 10 by 2 years (4.6%), and 16 by 5
years (7.4%). A further four patients re-presented between years 5 and
8. The timelines of recurrence are displayed in Figure 5 and the clinical
and procedural details are presented in Table 3. For all 20 patients with
recurrence, their status at the original procedure (left side of Table 3)
was as follows: mean age 64.1 years, 13 male (65%), and 2 diabetic, 9
elective, and 11 nonelective. The median (IQR) estimate of in-patient
mortality by the logistic EuroSCORE-1 was 2.83% (0.88-11.1%). The
FIGURE 3 OCT images of patients who had undergone SKS deployment previously. These are representative images from five different
patients. For consistency, all images are taken in the LMS in the LMS-LAD stent, with the neocarina visible between that stent and the
LMS-Cx stent. There is a continuous coverage of tissue between the struts of the neocarina in panels A-D. Panels E and F taken from the
same patient; the diaphragm is unfenestrated at the neocarina but is fenestrated towards the ostium. An OCT video pullback in SKS is view-
able online. SKS barrels are visible from 20 s [Color figure can be viewed at wileyonlinelibrary.com]
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mean (SD) SYNTAX score was 29.9 (12.4) and 7 patients had a SYN-
TAX score >32. Eight patients were unsuitable for CABG. In those
with symptomatic recurrence, the SKS procedure had used first genera-
tion DES in 13 and second generation in 7. The original mean stent
sizes were 3.25 3 22.21 mm in the LMS-LAD and 3.06 3 24.25 mm in
the LMS-Cx. The clinical details of the 20 patients with recurrence are
shown in Table 3. The mean time to presentation was 30.8 (SD 32)
months. Presentation was with chronic stable symptoms in 9, urgent in
7, and as an emergency procedure in 4. The recurrence rate at 2 years
for the first generation DES was 7/132 (5.3%) and for the second gen-
eration 4/108 (3.7%) (P50.50). The sites of restenosis were the LMS-
Cx ‘barrel’ in 7/20 (35%), LMS-LAD ‘barrel’ in 2/20 (10%), and both in
11/20 (55%).
3.6 | Repeat revascularization
Of the 20 patients with clinical recurrence, one was treated with CABG
because of occlusive in-stent restenosis in the right coronary artery
(RCA) as well as restenosis in the SKS. The remaining 19 patients were
treated with repeat PCI, which was feasible in all cases. It was possible
to pass guidewires, balloons, IVUS catheters and stents through the
original stents. In the early patients, simultaneous kissing balloons
(SKB) were used as definitive treatment, in an attempt to avoid the
placement of a second stent layer. When second generation DES
became available, repeat SKS was employed. Therefore, in total, repeat
SKS was performed in nine patients, SKB (drug-eluting when available)
in five, and a combination of stent and balloon (SKS/B) in five. The
mean stent sizes used at the second procedure were 3.2 3 22 mm in
the LMS-LAD and 3.2 3 24 mm in the LMS-Cx. Examples of restenosis
and repeat SKS are shown in Figures 6 and 7 and the Supporting Infor-
mation Video case. One patient with active rheumatoid disease,
impaired left ventricular function and severe ischemia had extensive
restenosis throughout multiple stents and arteries. This patient (Case 8)
died with pulmonary edema and shock during the second PCI. Of the
surviving patients, re-restenosis occurred in 4/19 patients. Two cases
re-represented within 1 year (cases 7 and 14). Case 7 was treated with
FIGURE 4 OCT study of a LMS SKS case recorded 4 months post-PCI. Panel A is taken from the LMS-LAD limb and Panel B from the
LMS-LCX limb. The middle third of each 3D cut-away demonstrates the neo-carina or ‘diaphragm’, a sheet of endothelium which covers the
stent adjoining the two limbs in the LMS section. The catheter is seen in the right third and the LAD (A) and LCX (B) segments are in the
left third. The cross-sectional OCT view (taken at the mid-LMS point) shows the adjacent barrel [Color figure can be viewed at wileyonlineli-
brary.com]
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SKB with DEB (SKS, SKS, SKB) and case 14 was treated with SKS (SKS,
SKB, SKS). Case 3 re-represented 98 months after the first recurrence
and was treated with a single stent to the LAD because the LCx had
become chronically occluded (SKS, SKS-B, single). Case 9 re-
represented ten years after their first recurrence and was treated with
SKB (SKS, SKB, SKB). None of the other patients, including those
treated with repeat SKS for their initial restenosis, experienced further
symptoms or problems.
4 | DISCUSSION
This is the first analysis of SKS that addresses the detailed technical
issues related to the sustainability of the SKS technique. Computational
modelling revealed even expansion of the stents to their nominal diam-
eter, without distortion, uneven cell opening or large gaps. This con-
trasts with the pattern seen in stents used with other bifurcation
techniques. However, the ‘virtual’ artery was undiseased and, in the
‘real world’, with eccentric calcific plaque formation, it is common to
see differential expansion at moderate pressure with any technique.
Each stent in the LMS take on an oval cross-section, seen in our OCT
images. We also noted that the two inner channels exhibited increased
blood flow velocity in the proximal LMS. Largely undisturbed blood
flow was found through the stents, with only a small recirculation zone
at the ostium of the Cx [16,17]. This reflects the smooth curve
between LMS and branch arteries, and contrasts with two-stent strat-
egies with more angulation, such as ‘T’ [18,19]. The gaps in the LMS
between the stents and the LMS wall matched our findings of SKS
deployment in undiseased porcine arteries in our first publication [6],
but have not been seen clinically, and none of our OCT images showed
this. This might happen clinically in the rare case of a highly localized
tight bifurcation stenosis with a long and completely normal LMS; but
in such a case SKS would not be recommended.
The OCT study of re-endothelialization and healing was driven by
concern about the exposed metal carina. We observed that all of the
stent struts at the carina were endothelialized from 4 months onwards.
Furthermore, of the 13 patients studied, seven had a carina that was
completely covered with tissue without visible fenestrations. Differen-
ces in coverage of SKS may also depend on the stent type, particularly
older generation DES [20]. Having previously recommended lifelong
dual antiplatelet therapy for patients with SKS, with the advent of thin-
strut second generation DES we now recommend a duration of 3
years.
The clinical recurrence rate in our patients was 3.2% at 1 year and
4.6% at 2 years. This compares favorably with other ‘real world’
TABLE 2 Optical coherence tomography (OCT) findings in patients
treated with simultaneous kissing stents for unprotected left main
stem bifurcation disease
Case
Time from PCI
to OCT (months)
All struts
covered?
Fenestrated
diaphragm?
4 3 No Fenestrated
1 4 Yes Unfenestrated
6 4 Yes Fenestrated
2 5 Yes Mixedc
9 6 Yes Mixed
11 11 Yes Unfenestrated
3 12 Yes Unfenestrated
15 12b Yes Unfenestrated
8 12 Yes Fenestrated
12 15 Yes Unfenestrated
13 17 Yes Unfenestrated
5 48 Yes Unfenestrated
14 120a Yes Unfenestrated
Abbreviations: Cx, circumflex; ISR, in-stent restenosis; LAD, left anterior
descending; LMS, left main stem; Mixedc, a complete, unfenestrated dia-
phragm at the carina but with fenestrations proximally towards the LMS
ostia.
aCase 14 was studied ten years after re-do SKS.
bCase 15 was studied twelve months after re-do SKS.
FIGURE 5 Timelines for restenosis after PCI to LMS with SKS. The 20 patients with symptomatic recurrence, out of our series of 217
treated with this technique, are listed in temporal order of the index PCI. The start of the solid line indicates the date of the index PCI and
the end of the line indicates the second procedure. Four cases experienced re-restenosis, here the end of the dotted line indicates the third
procedure [Color figure can be viewed at wileyonlinelibrary.com]
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TABLE 3 Characteristics of the 20 patients with symptomatic recurrence after SKS
Case Age Sex
Date
of SKS Urgency Medina DM
Euroscore
(%) SYNTAX
CABG
app? Stent 1 Stent 2
Months
to TVR Urgency
Location
of ISR Treatment Stent 1 Stent 2
1 54 M 04/2005 R 1,1,0 0 0.50 22 Yes Tax 2.75 Tax 3.00 88 R Cx SKS PE 3.5 PE 3.5
2 81 M 06/2005 U 1,1,1 0 56.00 44 No Tax 3.00 Tax 3.00 26 U Cx SKB - - - -
3 64 F 06/2005 U 1,1,1 0 4.00 23 Yes Tax 2.75 Tax 2.75 10 R Cx SKS Tax 2.75 Tax 2.75
4 58 M 09/2005 R 1,1,0 0 0.90 21 Yes Tax 3.50 Tax 3.50 7 U Cx and LAD SKS Tax 3.5 Tax 3.5
5 57 M 11/2005 R 1,1,0 0 1.30 38 Yes Tax 3.00 Tax 3.00 12 R LAD SKS Tax 3 Tax 4
6 69 M 06/2006 R 1,1,1 0 1.70 48 Yes End 2.75 End 2.75 4 R Cx (occluded)
and LAD
Single /SKB Tax 3 - -
7 46 M 10/2006 R 1,1,1 0 0.88 30 Yes Tax 2.75 Tax 2.75 121 R Cx SKS ISAR 3.5 ISAR 3
8 58 M 10/2006 R 1,1,1 0 0.88 30 Yes Tax 3.00 Tax 2.50 11 Em Cx and LAD SKS PP 3 PP 2.5
9 55 M 12/2006 R 1,1,1 0 0.12 24 Yes Tax 2.50 Tax 3.00 4 R Cx and LAD SKB - - - -
10 73 F 05/2007 U 1,1,1 0 35.00 14 No Tax 3.00 Tax 3.00 32 U LAD Single/SKB PP 3.5 - -
11 61 F 11/2007 U 1,0,1 0 5.98 16 No Tax 2.75 Tax 2.75 80 U Cx and LAD SKS PP 3 PP 3
12 82 F 03/2008 E 1,1,0 1 14.03 29 No Tax 3.00 Tax 3.00 66 U Cx and LAD SKS PP 3 PP 3
13 83 M 06/2008 R 1,1,1 0 27.25 42 No Tax 3.00 Tax 3.00 5 U Cx SKB - - - -
14 72 M 09/2008 U 1,1,1 0 16.13 58 No Tax 3.00 Tax 3.00 9 R Cx and LAD SKB (DEB) - - - -
15 49 M 08/2009 E 1,1,1 1 3.95 37 No PP 4.00 PP 3.00 17 R Cx and LAD
(1 RCA)
CABG - - - -
16 53 F 03/2011 R 1,1,0 0 0.62 13 Yes PE 3.00 PE 3.00 38 R Cx SKB - - - -
17 64 F 03/2011 U 1,1,1 0 4.90 29 No PE 3.00 PE 3.00 34 R Cx and LAD Single /SKB Res 3 - -
18 54 M 03/2015 E 1,1,1 0 0.72 30 No PP 3.00 Xi 3.00 27 Em Cx Sinlge /SKB - Onyx 3
19 69 F 06/2015 E 1,0,1 0 10.00 12 No PP 3.50 PP 3.00 12 U Cx and AD SKS PP 3.5 PP 3.5
20 80 M 01/2016 R 1,1,1 0 1.10 38 No PP 3.00 PP 3.50 13 Em Cx and LAD Single/SKB Onyx 3.5 - -
Abbreviations: CABG app’?, coronary artery bypass graft surgery potenially appropriate?; Cx, left circumflex artery; DEB, drug eluting balloon; DM, diabetes mellitus; E, emergency; End, endeavor; F, female;
LAD, left anterior descending artery; M, male; PE, promus element; PP, promus permier; R, routine; RCA, right coronary artery; Res, resolute; SKB, simultaneous kissing balloons; SKS, simultaneous kissing
stents; U, urgent; Tax, Taxus; TVR, target vessel revascularization.
Age at the index procedure. Stent sizes are diameters (mm). Stent 1 and 2 indicates the stents deployed to the LMS-LAD and LMS-Cx barrels, respectively. Cases are listed in the same order as shown in
Figure 4. The patients’ details at the time of their first procedure are presented in the left hand side, and on the right are relevant details at the time of their second procedure.
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registries, although it is difficult to make like-for-like comparison, due
to heterogeneity in the clinical setting (notably the clinical risk, and the
balance of acute or stable disease), the PCI technique (SKS, culotte,
crush, or T-stenting), stent types (BMS or first or second-generation
DES in other studies) and follow up period. Gao et al. [21] reported a
TVR rate of 8.6% over 4 years in 372 bifurcation ULMS cases treated
with a two-stent technique, but only 12% were SKS. In a study of
1874 patients, Chieffo et al. [22] reported a TVR rate of 15.5% over
3.5 years, although only 40% were ‘true bifurcation’ cases and only
first-generation DES were included. In the SYNTAX trial, the repeat
revascularization rate was 12% at 1 year and 27% at 5 years in those
with isolated LMS disease [23,24]. In a separate series employing
sirolimus-eluting stents (SKS 68%), the TLR rate was 38%, although it
was ischemia-driven in 14% [25]. Kim et al employed sirolimus-eluting
stents in 36 patients, with a target lesion revascularisation rate of 14%
[26]. The DKCRUSH-III trial compared the double-kissing crush tech-
nique with a culotte strategy in bifurcation ULMS disease [27] and
reported one and 2-year TVR rates of 11.1% and 17.1 for culotte
stenting and 4.3% and 4.8% for DK crush. Unlike our all-comer study,
DKCRUSH-III excluded patients with recent and acute myocardial
infarction and severe left ventricular systolic dysfunction and those
with heavy calcification at angiography.
In the 20 cases in our cohort with clinical recurrence, neointima
was observed in the LMS-Cx stent in 7, the LMS-LAD stent only in 2
and both in 10. The Cx is a common site of restenosis for any two-
stent technique at the LMS [25,28]. A possible explanation for the
excess of Cx restenosis may be that the angulation predisposes to
reduced stent expansion, wide cell opening, poor metal coverage, and
reduced drug delivery on the ‘greater curve’, with (as we have demon-
strated) disturbed flow on the ‘lesser curve’.
Repeat PCI as the treatment for restenosis in SKS was used as
default treatment in our patients, and was feasible and acutely success-
ful in all 19 cases undertaken. Usually the first guidewire passed
uneventfully. Typically, the second guidewire required a few minutes of
manipulation, or alteration of guide catheter angle, to advance correctly
through the other stent. If a balloon failed to pass immediately, it was
assumed that the wire had traversed a stent fenestration, so the wire
was withdrawn and re-directed, allowing equipment to advance. A
small wire loop was sometimes helpful. The re-PCI was then safely and
effectively accomplished. The DEB balloon approach was feasible, as
was repeat SKS. A summary of tips and tricks is included in the Sup-
porting Information Appendix and a repeat SKS case is demonstrated
in the Supporting Information Video 2.
This study has several limitations. First, the simulations were based
upon relatively low pressure deployment into a healthy ‘virtual’ artery
(nominal pressure of 9 atm. The lacunae seen at the vessel carina in the
simulation were not seen in our clinical OCT study in patients who had
significant plaque disease. Similarly, the constraints imposed by
FIGURE 6 First example of restenosis in SKS and its treatment with SKS (Case 17 in Table 3). An obese diabetic female patient aged 70
years had undergone implantation of a Sorin 21 mm prosthetic aortic valve replacement in 2003. She developed angina in 2015, was found
to have a bifurcation LMS lesion, and this was successfully stented using SKS (3.5 3 20 mm and 3.0 3 16 mm Promus PremierTM stents).
She represented with crescendo angina 1 year later while taking triple antithrombotic therapy. Repeat coronary angiography demonstrated
restenosis at the bifurcation, affecting both limbs of the SKS (A), whilst the original stents appeared well deployed. Two wires were passed
and predilatation was performed with simultaneous kissing 3.0 mm balloons at high pressure (B). Repeat SKS was undertaken using 3.5 3
20 and 3.5 3 16 mm Promus PremierTM DES at 16 atm (C). The final result was excellent (D). Recovery was uneventful and she was
asymptomatic 1 year later. This case is also demonstrated as a video in the Online Supporting Information
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diseased arteries led to the ovoid cross section with a flattened carina
clearly and consistently seen in our OCT images. Second, the number
of patients restudied, either electively or for symptom recurrence, was
relatively small. Nevertheless, they constitute the largest group with
SKS investigated systematically. Third, it is difficult to compare the
results reported here with those from other registries or studies of
two-stent techniques because of the high-risk case-mix. Fourth, control
angiography was only performed for recurrent symptoms, so subclini-
cal, mild, angiographic restenosis could not be documented.
5 | CONCLUSION
SKS is an effective PCI treatment for patients with disease at the LMS
bifurcation who require a two-stent approach, and is particularly useful
in the emergency situation. The stents are deployed with minimal dis-
tortion, the blood flow pattern is favorable, the struts of the neocarina
become covered with tissue either individually or in a continuous sheet,
the clinical restenosis rate is low, and re-PCI is safe and feasible with a
repeat SKS approach.
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